NICOLE MISIASZEK: Open Payments
NPI 1770772063 · ENFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,495 in 170 payments from 31 companies in 2025. Trend: 2023 $3,113 · 2024 $2,755 · 2025 $3,495
Food & beverage: $3,495
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $567 |
| AstraZeneca Pharmaceuticals LP | 18 | $426 |
| Novo Nordisk Inc | 11 | $277 |
| Otsuka America Pharmaceutical, Inc. | 13 | $229 |
| GlaxoSmithKline, LLC. | 11 | $220 |
| PFIZER INC. | 12 | $200 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $185 |
| Lundbeck LLC | 8 | $161 |
| Azurity Pharmaceuticals, Inc. | 6 | $129 |
| Lilly USA, LLC | 6 | $128 |
Products named: REXULTI, VRAYLAR, BREZTRI, AIRSUPRA, TRELEGY ELLIPTA, Wegovy, UBRELVY, JARDIANCE.
Industry payments across CT — which companies pay providers there.
